HIV medication adherence and substance use: The smartest women's project

American Journal of Infectious Diseases

Volumn 3, Issue 4, 2007, Pages 240-247

  Lopez, Eliot ^a   Jones, Deborah L ^b   Ishii, Mary ^a   Tobin, Jonathan N ^c   Weiss, Stephen M ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b BARRY UNIVERSITY   (United States)

^c Clinical Directors Network   (United States)

Author keywords

Adherence; Antiretroviral therapy; Psychosocial; Substance use; Women

Indexed keywords

EID: 38849145634     PISSN: 15536203     EISSN: None     Source Type: Journal    
DOI: 10.3844/ajidsp.2007.240.247     Document Type: Article

References (36)

1. Paterson, D.L., B., Potoski and B. Capitano, 2002. Measurement of adherence to antiretroviral medications. J. Acquired Immune Def. Syndr., 31 (Suppl.3): S103-S106.
2. Paterson, D.L., S. Swindells, J. Mohr, M. Brester, E.N. Vergis and C. Squier et al., 2000. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann. Int. Med., 133 (Suppl. 1): 21-30.
3. Deeks, S., G. Beatty, P.T. Cohen, R. Grant and P. Volberdink, 1998. Viral load and CD+ T cell changes in patients failing potent protease inhibitor therapy. [abstract]. 5th Conference on Retroviruses and Opportunistic infections, Chicagg, IL.
4. Boden, D., A. Hurley, L., Zhang, Y. Cao, Y. Guo and E. Jones et al., 1999. HIV-1 drug resistance in newly infected individuals. J. Am. Med. Assoc., 282: 1135-1141.
5. Carpenter, C.C.J., M.A Fischl, S.M. Hammer, M.S. Hirsch, D.M. Jacobsen, D.A. Katsenstein and J.S.G Montaner et al., 2000. Antiretroviral therapy in adults updated recommendations of the international AIDS society-USA panel. J. Am. Med. Assoc., 283: 381-390.
6. Hogg, R.S., B. Yip, K. Chan, M.V. O'Shaughnessy J.S.V. Montaner, 2000. Non-adhorence to triple combination is predictive of AIDS progression and death in HIV positive men and women. 7th Conf. Retroviruses and Opportunistic Infections.
7. Reiter, G.S., K.E. Stewart and L. Wojtusik, 2000. Elements of success in HIV clinical care: Multiple interventions that promote adherence. Topics in HIV Medicine; 8 (Suppl.5): 21-30.
8. Mcpherson-Baker, S., R. Malow, F. Penedo, D. Jones, N. Schneiderman and N. Klimas, 2000. Enhancing'adherence to combination antiretroviral therapy in non-adherent HIV-positive men. AIDS Care, 12: 399-404.
9. Chander, G., Lau, B., & Moore, R.D. 2006. Hazardous alcohol use: A risk factor for non-adherence and lack of suppression in HIV infection. J. Acquir. Immune Defic. Syndr., 43: 411-417.
10. Hinkin, C.H., T.R. Barclay, S.A. Castellon, A.J. Levine, R.S. Durvasula and S.D. Marion et al. 2007. Drug use and medication adherence among HIV-1 infected individuals. AIDS and Behavior, 11: 185-194.
11. Shannon, K., T. Kerr, C. Lai, T. Ishida, E. Wood and J.S. Montaner et al., 2005. Nonadherence to antiretroviral therapy among a community with endemic rates of injection drug use. J. Intl. Assoc. Physicians in AIDS Care, 4: 66-72.
12. Liu, H., D. Longshore, J.K. Williams, I. Rivkin, T. Loeb and U.S. Warda, et al., 2006. Substance abuse and medication adherence among HIV-positive women with histories of child sexual abuse. AIDS and Behavior, 10: 279-286.
13. Wong, M.D., W.E. Cunningham, M.F. Shapiro, R.M. Andersen, P.D. Cleary and N. Duan et al., 2004, Disparities in HIV treatment and physician attitudes about delaying protease inhibitors for nonadherent patients. J. Gen. Int. Med., 19: 366-374.
14. Segal-Isaacson, C.J., J.N. Tobin, S.M. Weiss, E. Brondolo, A. Vaughn and C. Wang et al. Improving Dietary Habits In Disadvantaged Women With HIV/AIDS: The SMART/EST Women's Project (in press, AIDS & Behavior)
15. Chesney, M. and J. Ickovics, 1997. For the recruitment, adherence and retention committee of the ACTG: Adherence to combination therapy in AIDS clinical trials. Presented at the Annual Meeting of the AIDS Clinical, Trials Group, Washington, D.C.
16. Beck, A.T., R.A. Steer and M.G. Garbin, 1988. Psychometric properties of the BDI: 25 years later. Clin. Psychol. Rev., 8: 77-100.
17. Beck, A.T., C.H. Ward, M. Mendelson and J. Erbaugh, 1961. An inventory for measuring depression. Arch. Gen. Psych., 4: 561-571.
18. Horne, R., J. Weinman and M. Hankins, 1991. The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication. Psychology and Health, 12: 1-24.
19. Carver, C., M. Sheier and J.D. Weintraub, 1989. Assessing coping strategies: A theoretically based approach. J. Person. Soc. Psychol., 56: 267-283.
20. Bandura, A., 1995. Self-efficacy and changing societies. New York: Cambridge University Press.
21. Creuss, S., M.H. Antoni, A. Hayes, F.J. Penedo, G. Ironson and M.A. Fletcher et al., 2002. Changes in mood and depressive symptoms and related change processes during cognitive behavioral stress management in HIV-infected men. Cogn. Ther. and Res., 26: 373-392.
22. Beck, A.T., J. Rush, B. Shaw and G. Emery, 1979. Cognitive therapy of depression. New York: Guilford.
23. Barre-Sinoussi, F., J.C. Chermann, F. Rey, M.T. Nugeyre, S. Chamaret and J. Gruest, 1983. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science, 220: 868-871.
24. Kievits, T., B. van Gemen, D. van Strijp, R. Schukkink, M. Dircks and H. Adriaanse, 1991. NASBA isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection. J. Virol. Methods, 35: 273-286.
25. Arnsten, J.H., P.A. Demas, R.W. Grant, M.N. Gourevitch, H. Farzadegan and A.A. Howard et al., 2002. Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J. Gen. Int. Med., 17: 377-381.
26. Catz, S.L., J.A. Kelly, L.M. Bogart, E.G. Benotsch, and T. Mcauliffe, 2000. Patterns, correlates and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychol., 19 (Suppl.,2): 124-133.
27. Gordillo, V., J. Del Amo, V. Soriano and J. Gonzlez-Lahoz, 1999. Sociodemographic and psychological variables influencing adherence to antiretroviral.therapy. AIDS, 113 (Suppl. 13): 1763-1769.
28. Remien, R.H., A.E. Hirky, M.O. Johnson, L.S. Weinhardt, D. Whittier and G. Minh Le, 2003. Adherence to medication treatment: A qualitative study of facilitators and barriers among a diverse sample of HIV+ men and women in four U.S. cities. AIDS and Behavior, 7 (Suppl. 1):61-71
29. Bogenschutz, M.P., J.S. Tonigan and-W.P. Miller, 2006. Examining the effects of alcoholism typology and AA attendance on self-efficacy as a mechanism of change. J. Studies on Alcohol, 67: 562-567.
30. Barclay, T.R., C.H. Hinkin, S.A. Castellon, K.I. Mason, M.J. Reinhard and S.D. Marion et al. 2007. Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy and neurocognitive status. Health Psychol., 26, 40-49.
31. Jones, D.L., S. MacPherson-Baker, D. Lydston, Y. Gousse, E. Brondolo, J. Camille, J.N. Tobin and S.M. Weiss, 2007. Influencing medication adherence among HIV+women. The SMART/EST II Women's Project. AIDS & Behavior, 11: 79-86.
32. Wagner, G.J., R.H. Remien, A. Carballo-Dieguez, and C. Dolezal, 2002. Correlates of adherence to combination antiretroviral therapy among members of HIV-ppsitive mixed status couples. AIDS CARE, 14 (Suppl. 1): 105-109.
33. Malcolm, S.E., J.J. Ng, R.K. Rosen and V.E. Stone, 2003. An examination of HIV/AIDS patients who have excellent adherence to HAART. AIDS Care, 15 (Suppl. 2): 251-261.
34. Sankar, A., M. Luborsky, P. Schuman and G. Roberts, 2002. Adherence discourse among African-American women taking HAART. AIDS Care, 14 (Suppl.2): 203-218.
35. Bangsberg, D.R., F.M. Hecht, H. Clague, E.D. Chalebois, D. Ciccarone and M. Chesney et al., 2001. Provider Assessment of Adherence to HIV Antiretroviral Therapy. J. Acquir. Immune Defic. Syndr., 26 (suppl. 5):435-442.
36. Hill, Z., C. Kendall and M. Fernandez, 2003. Patterns of Adherence to Antiretrovirals: Why Adherence Has No Simple Measure. AIDS Patient Care STDs, 17 (Suppl 10): 519-525.